Your browser doesn't support javascript.
loading
The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption.
Pan, Guo-Yu; Huang, Zhi-Jiang; Wang, Guang-Ji; Fawcett, J Paul; Liu, Xiao-Dong; Zhao, Xiao-Chen; Sun, Jian-Guo; Xie, Yuan-Yuan.
Afiliação
  • Pan GY; Center of Pharmacokinetics, China Pharmaceutical University, Nanjing, China.
Planta Med ; 69(7): 632-6, 2003 Jul.
Article em En | MEDLINE | ID: mdl-12898419
ABSTRACT
The mechanism of action of berberine as an antihyperglycaemic agent was investigated in the Caco-2 cell line. Berberine was found to effectively inhibit the activity of disaccharidases in Caco-2 cells. It also decreased sucrase activity after preincubation with Caco-2 cells for 72 hours. However gluconeogenesis and glucose consumption of Caco-2 cells were not influenced. 2-Deoxyglucose transporting through Caco-2 cell monolayers was decreased by berberine but the effect was not statistically significant. These results suggest that the antihyperglycaemic activity of berberine is at least partly due to its ability to inhibit alpha-glucosidase and decrease glucose transport through the intestinal epithelium.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Berberina / Inibidores Enzimáticos / Glucose / Hiperglicemia / Hipoglicemiantes Limite: Humans Idioma: En Ano de publicação: 2003 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Berberina / Inibidores Enzimáticos / Glucose / Hiperglicemia / Hipoglicemiantes Limite: Humans Idioma: En Ano de publicação: 2003 Tipo de documento: Article